Descripción

Concluding summary of key findings from the Euglena gracilis fermentate trial, including effect sizes for primary immune function endpoints.

Figure 36

Source Paper

Effect of a Euglena gracilis Fermentate on Immune Function in Healthy, Active Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.

Nutrients (2019)

PMID: 31816842

DOI: 10.3390/nu11122926

Cite This Figure

![Figure 36: Concluding summary of key findings from the Euglena gracilis fermentate trial, including effect sizes for primary immune function endpoints.]()

> Source: Malkanthi Evans et al. "Effect of a Euglena gracilis Fermentate on Immune Function in Healthy, Active Ad." *Nutrients*, 2019. PMID: [31816842](https://pubmed.ncbi.nlm.nih.gov/31816842/)

<figure>
  <img src="" alt="Concluding summary of key findings from the Euglena gracilis fermentate trial, including effect sizes for primary immune function endpoints." />
  <figcaption>Figure 36. Concluding summary of key findings from the Euglena gracilis fermentate trial, including effect sizes for primary immune function endpoints.<br>  Source: Malkanthi Evans et al. "Effect of a Euglena gracilis Fermentate on Immune Function in Healthy, Active Ad." <em>Nutrients</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31816842/">31816842</a></figcaption>
</figure>

Evidencia relacionada

Beta-Glucan para Upper Respiratory Tract Infections

Calificación A · 13 estudios